1. Home
  2. NSPR vs MATH Comparison

NSPR vs MATH Comparison

Compare NSPR & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$0.91

Market Cap

39.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
MATH
Founded
2005
2015
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
39.7M
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
NSPR
MATH
Price
$0.72
$0.91
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
39.9K
26.6K
Earning Date
05-04-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$3.10
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.80
52 Week High
$2.59
$4.10

Technical Indicators

Market Signals
Indicator
NSPR
MATH
Relative Strength Index (RSI) 51.86 42.75
Support Level $0.69 $0.86
Resistance Level $0.72 $1.17
Average True Range (ATR) 0.03 0.10
MACD 0.01 0.00
Stochastic Oscillator 89.14 29.55

Price Performance

Historical Comparison
NSPR
MATH

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

Share on Social Networks: